Clinical Trial Detail

NCT ID NCT04454489
Title Quad Shot Radiotherapy in Combination With Immune Checkpoint Inhibition
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Wake Forest University Health Sciences
Indications

head and neck squamous cell carcinoma

Therapies

Pembrolizumab

Age Groups: adult senior

No variant requirements are available.